Agoracom: Small Cap Investment - Resverlogix Corp. - Zacks SCR Resverlogix R&D Update 10/17/16

...We Welcome You To The Resverlogix HUB withIn The AGORACOM COMMUNITY!

Reply New Message

Back To Forum List View

BearDownAZ

Rank: President [?]

Points: 25003 [?]

Votes: 68 Score: 4.5 [?]

Your Vote:

Please Log In to Vote

Did you know? You can earn activity points by filling your profile with information about yourself (what city you live in, your favorite team, blogs etc.)

Zacks SCR Resverlogix R&D Update 10/17/16

posted on Oct 18, 2016 06:37AM

Resverlogix Hosts KOLs for Presentations on Diabetes, CKD and Apabetalone Trials

Zacks SCR analyst John Vandermosten released a research report update on Resverlogix on 10/17/16 focused on the recent Resverlogix R&D update. I haven't received confirmation from IR at Resverlogix, but I am pretty sure that John Vandermosten counts as 1 of the 3 new analysts for 2016. Although Zacks has been covering RVX for some time before 2016, John has apparently replaced the previous analyst(s) at Zacks covering RVX.....so technically he is a new RVX analyst. He released his "initiating coverage" report back in June 2016.